- Home
- OPT
OPT
Opthea Limited
as 07-26-2024 4:00pm EST
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.
| Founded: | N/A | Country: | Australia |
| Employees: | N/A | City: | N/A |
| Market Cap: | 190.7M | IPO Year: | 2020 |
| Target Price: | $15.00 | AVG Volume (30 days): | 14.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.69 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.60 - $4.40 | Next Earning Date: | 08-06-2024 |
| Revenue: | $385,275 | Revenue Growth: | 93.60% |
| Revenue Growth (this year): | -48.01% | Revenue Growth (next year): | N/A |
Latest Opthea Limited News
OPT Breaking Stock News: Dive into OPT Ticker-Specific Updates for Smart Investing
GlobeNewswire
10 days ago
Opthea Welcomes International Retina Thought Leaders to Join Its Medical Advisory Board
GlobeNewswire
12 days ago
Opthea Announces Results of the A$55.9m (US$36.9m¹) Retail Entitlement Offer
GlobeNewswire
18 days ago
Opthea Announces Publication on VEGF-C and D Signaling Pathways as Potential Targets for Treatment of Wet AMD
GlobeNewswire
a month ago
Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens
GlobeNewswire
a month ago
Opthea Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$171.5 million (US$113.2m¹)
MT Newswires
a month ago
Opthea to Raise $150.4 Million Through Placement, Entitlement Offers
GlobeNewswire
a month ago
Opthea Announces Placement and Partially Underwritten Entitlement Offer to Raise up to Approximately A$227.3 million (US$150.0 million¹)
CNW Group
2 months ago
Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku
Compare OPT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OPT Opthea Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.